Stocks

Stoke Therapeutics STOK

Health care sectorNasdaq

What to see in Stoke Therapeutics now

Who bought more than 5%?5.6%

Biotechnology Value Fund holds 5.6%

Filed 09/30
Is Wall Street adding or cutting?0

198 13F filers hold it · +0 against the quarter before · shares held +8.8%

Holdings of 06/30

Company

Exchange
Nasdaq
Industry
Pharmaceutical Preparations
Headquarters
Bedford, Massachusetts
Fiscal year end
12/31
Next earnings
10/30, estimated
  • Biotechnology Value Fund holds 5.6%Filed 09/30
  • 198 13F filers hold it · +0 against the quarter before · shares held +8.8%Holdings of 06/30

Funds

13F filers: 198 · 0 since the quarter before · 06/30 holdings

Famous funds that held Stoke Therapeutics in their latest 13F report.

FundValueSince the quarter before
Mirae Asset Global ETFS HoldingsStoke Therapeutics STOK · 06/30 holdings$2.6MNo quarter before
Mirae Asset Global InvestmentsStoke Therapeutics STOK · 06/30 holdings$91.1KTrimmed −6.5%
All tracked funds

5% stakes

Holder
Biotechnology Value Fund09/305.6%3,608,968 shFirst report
Lynx1 Capital Management08/146.5%4,038,404 sh−1.6pp
Toronto Dominion Bank08/124.9%3,173,258 sh−0.5pp
FMR08/068.5%5,313,100 sh−1.3pp
Lynx1 Capital Management05/188.1%4,763,673 sh+1.1pp
Redmile Group05/156.7%4,164,120 sh−1.3pp
Wellington Management Group05/155.2%3,095,700 shFirst report
FMR02/059.8%5,600,920 sh−2.7pp
Cowen Financial Products25/11/140%0 sh−5.8pp
Toronto Dominion Bank25/11/145.8%3,173,258 shFirst report
FMR25/11/0512.5%6,865,057 sh−1.1pp
BlackRock25/10/176.8%3,732,540 sh+1.0pp
Skorpios Trust25/08/264.1%2,256,181 sh−1.9pp
FMR25/08/0613.6%7,412,982 sh+2.9pp
BlackRock Portfolio Management25/07/154.7%2,550,341 sh−0.4pp
Skorpios Trust25/06/236%3,256,181 sh−1.2pp
Skorpios Trust25/06/067.2%3,906,181 sh−5.8pp
FMR25/06/0610.7%5,859,011 shFirst report
BlackRock Portfolio Management25/04/155.1%2,743,502 shFirst report
Skorpios Trust24/12/2713%6,906,181 shNo earlier report
All 5% stake reports on Stoke Therapeutics

26-week trading